Non-compaction cardiomyopathy: clinical forms, outcomes and survival in a cohort of belarusian patients

Non-compaction cardiomyopathy: clinical forms, outcomes and survival in a cohort of belarusian patients

The aim is to evaluate the results of long-term follow-up of patients with various clinical forms of NCCM, associated clinical outcomes, as well as 3-year survival.Materials and methods. 211 patients with NCCM (median age 39 [18; 72] years) were examined, of which: 94 (44.5 %) were diagnosed with an...

Bibliografiset tiedot
Päätekijät:	S. M. Komissarova, O. V. Krasko, N. M. Rinejskaya, T. V. Sevruk, A. A. Efimova
Aineistotyyppi:	Artikkeli
Kieli:	Russian
Julkaistu:	InterMedservice 2022-05-01
Sarja:	Евразийский Кардиологический Журнал
Aiheet:	non-compaction cardiomyopathy sudden cardiac death orthotopic heart transplantation implantation of a cardioverter defibrillator
Linkit:	https://www.heartj.asia/jour/article/view/6328

Samankaltaisia teoksia

Implantable cardioverter defibrillators for primary prevention in cardiomyopathies
Tekijä: Vineetha Kanneganti, et al.
Julkaistu: (2024-03-01)

Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
Tekijä: Murillo Oliveira Antunes, et al.
Julkaistu: (2024-12-01)

Life‐threatening peripartum cardiomyopathy—Not expected when expecting
Tekijä: Peter Magnusson, et al.
Julkaistu: (2019-06-01)

ICD Outcome in Pediatric Cardiomyopathies
Tekijä: Massimo Stefano Silvetti, et al.
Julkaistu: (2022-01-01)

Case report: Removal of a subcutaneous implantable cardiac defibrillator in a pediatric patient with hypertrophic cardiomyopathy after a septal myectomy. Insights on current indications of type of ICD in children with hypertrophic cardiomyopathy and left ventricular tract obstruction
Tekijä: Paola Dolader, et al.
Julkaistu: (2022-09-01)

S-ICD Implantation "Tips and Tricks"
Tekijä: Szymon Budrejko, et al.
Julkaistu: (2023-07-01)

Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy
Tekijä: Sarah A. Goldstein, et al.
Julkaistu: (2023-08-01)

Implantable cardioverter defibrillators: Uses, abuses, gains and complications
Tekijä: Weiwei Li, et al.
Julkaistu: (2017-04-01)

Patient Activity and Survival Following Implantable Cardioverter‐Defibrillator Implantation: The ALTITUDE Activity Study
Tekijä: Daniel B. Kramer, et al.
Julkaistu: (2015-05-01)

The first cardioverter defibrillator implanted in Central Africa
Tekijä: Tantchou Tchoumi Jacques Cabral, et al.
Julkaistu: (2016-03-01)

Clinical characteristics of various arrhythmogenic cardiomyopathy phenotypes in the pediatric population: a systematic review and meta-analysis
Tekijä: D. Yu. Alekseeva, et al.
Julkaistu: (2022-12-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
Tekijä: Boldizsar Kovacs, et al.
Julkaistu: (2019-11-01)

Association of QTc Interval and V4-S Wave With Appropriate ICD Therapy in Hypertrophic Cardiomyopathy
Tekijä: Nixiao Zhang, et al.
Julkaistu: (2022-05-01)

Low QRS voltage and atrial fibrillation precluding implantation of a subcutaneous implantable cardioverterdefibrillator in a patient with arrhythmogenic cardiomyopathy
Tekijä: Peter C. Kahr, et al.
Julkaistu: (2017-12-01)

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis
Tekijä: Jayasree Pillarisetti, MD, et al.
Julkaistu: (2015-01-01)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
Tekijä: Johnson Francis, et al.
Julkaistu: (2005-04-01)

Sudden cardiac death, aborted, in healthy 34-year-old Male
Tekijä: Hitesh Shah
Julkaistu: (2014-01-01)

CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
Tekijä: E. V. Privalova, et al.
Julkaistu: (2013-02-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
Tekijä: Arindam Pande, et al.
Julkaistu: (2016-01-01)

Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker
Tekijä: Paul S.G. Hong, MRCP, et al.
Julkaistu: (2015-01-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
Tekijä: L. A. Bokeria, et al.
Julkaistu: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
Tekijä: L. A. Bokeria, et al.
Julkaistu: (2019-02-01)

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
Tekijä: Johanna Mueller‐Leisse, et al.
Julkaistu: (2021-12-01)

Subcutaneous Implantable Cardioverter-defibrillator in Preventing Ventricular Arrhythmia and Sudden Cardiac Death – A Single-center Experience
Tekijä: Amarapalli Jayachandra, et al.
Julkaistu: (2024-08-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
Tekijä: Temirkhan Begisbayev, et al.
Julkaistu: (2022-05-01)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
Tekijä: Yae Min Park
Julkaistu: (2023-01-01)

Ventricular predominance in biventricular arrhythmogenic cardiomyopathy: Should new subtype criteria be recognized?
Tekijä: Santiago Luna-Alcala, MD, et al.
Julkaistu: (2024-06-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
Tekijä: N. V. Melnik
Julkaistu: (2018-01-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
Tekijä: Yusuke Kondo, M.D., Ph.D., et al.
Julkaistu: (2015-10-01)

Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator
Tekijä: Szymon Budrejko, et al.
Julkaistu: (2023-12-01)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
Tekijä: Yisachar Greenberg, et al.
Julkaistu: (2005-04-01)

Risk factors for mortality in post-myocardial infarction patients: insights from the improve SCA bridge study
Tekijä: Dileep Kumar, et al.
Julkaistu: (2024-06-01)

Implantable Cardioverter-Defibrillator in Dilated Cardiomyopathy after the DANISH-Trial Lesson. A Poly-Parametric Risk Evaluation Is Needed to Improve the Selection of Patients
Tekijä: Marcello Disertori, et al.
Julkaistu: (2017-10-01)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
Tekijä: Fabrizio Guarracini, et al.
Julkaistu: (2023-07-01)

Management of S‐ICD lead in a patient requiring sternotomy
Tekijä: Basil Saour, et al.
Julkaistu: (2019-07-01)

Management of Hypertrophic Cardiomyopathy
Tekijä: Alan D. Enriquez, et al.
Julkaistu: (2014-04-01)

Association between implantable cardioverter-defibrillator and survival in patients awaiting heart transplantation: A meta-analysis and systematic review
Tekijä: Andrew Y. Lin, MD, et al.
Julkaistu: (2021-12-01)

Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
Tekijä: Jose Maria Frutos Perez, et al.
Julkaistu: (2021-03-01)

Relevance of guideline-based ICD indications to clinical practice
Tekijä: Nora Al-Jefairi, et al.
Julkaistu: (2014-01-01)

Comparative Effectiveness of Primary Prevention Implantable Cardioverter‐Defibrillators in Older Heart Failure Patients With Diabetes Mellitus
Tekijä: Abhinav Sharma, et al.
Julkaistu: (2020-06-01)